Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers M > Headlines for Marksans Pharma Ltd. > News item |
Marksans Pharma seeks approval for $125 million in convertibles
By Devika Patel
Knoxville, Tenn., Feb. 8 - Marksans Pharma Ltd. informed the Bombay Stock Exchange that it will seek shareholder approval to issue up to $125 million in foreign currency convertible bonds via a postal ballot.
The company also is considering issuing other securities convertible into equity shares.
Marksans Pharma, based in Mumbai, India, is a pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.